Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Sets 45-Day Deadline For Listing Studies In ClinicalTrials.Gov

Executive Summary

FDA is asking manufacturers to submit information about ongoing clinical trials to the ClinicalTrials.gov website by early May

You may also be interested in...



Lilly Advocating National Clinical Database; Will Expand LillyTrials.com

Lilly is endorsing the concept of a national database for clinical trial results

Lilly Advocating National Clinical Database; Will Expand LillyTrials.com

Lilly is endorsing the concept of a national database for clinical trial results

ClinicalTrials.gov Compliance Will Improve, PhRMA Tells Rep. Waxman

Industry may need several years to come into complete compliance with ClinicalTrials.gov, the Pharmaceutical Research & Manufacturers of America indicated in a letter to Rep. Henry Waxman (D-Calif.)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel